Clinical Utility of Deucravacitinib for the Management of Moderate to Severe Plaque Psoriasis

INTRODUCTION: Psoriasis is a chronic, immune-mediated skin condition with significant detriments to physical/mental health. While systemic therapies are available for the treatment of moderate-to-severe psoriasis, patients can experience therapeutic failure, loss of efficacy, or medical contraindica...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Joy Q, Spencer, Riley K, Reddy, Vidhatha, Bhutani, Tina, Liao, Wilson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202110/
https://www.ncbi.nlm.nih.gov/pubmed/37223005
http://dx.doi.org/10.2147/TCRM.S388324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202110/
https://www.ncbi.nlm.nih.gov/pubmed/37223005
http://dx.doi.org/10.2147/TCRM.S388324

Ejemplares similares